NCT07091409

Brief Summary

We will investigate social cognition in patients with Borderline personality disorder (BPD) combined with electroencephalographic (EEG) measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 22, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 29, 2025

Completed
Last Updated

July 29, 2025

Status Verified

October 1, 2024

Enrollment Period

10 months

First QC Date

July 22, 2025

Last Update Submit

July 22, 2025

Conditions

Borderline Personality Disorder (BPD)

Outcome Measures

Primary Outcomes (1)

  • Number of accidental harm scenarios misclassified as intentional

    Accuracy

    20 Minutes

Study Arms (2)

Patients with BPD

Healthy individuals

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

BPD diagnosis and healthy participants

You may qualify if:

  • BPD diagnosis BMI between 17.5 and 30 acute major depressive episode, psychotic symptoms, substance addiction or acute suicidal behavior

You may not qualify if:

  • neurological, metabolic, endocrine, autoimmune and CNS diseases, any other severe somatic diseases, and pregnancy or breastfeeding during the last 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of Psychiatry, CBF

Berlin, 12203, Germany

Location

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

July 22, 2025

First Posted

July 29, 2025

Study Start

October 1, 2024

Primary Completion

July 20, 2025

Study Completion

July 20, 2025

Last Updated

July 29, 2025

Record last verified: 2024-10

Locations

DE(1)